おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Topigen Pharmaceuticals
company
About
TOPIGEN is a biotech company engaged in scientific research and development of novel therapeutic drugs.
- 51 - 100
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $6M
- Industries
- Biotechnology,Developer Tools,Product Research,Therapeutics
- Founded date
- Jan 1, 2000
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Topigen Pharmaceuticals is a biotechnology company that is focused on the scientific research and development of therapeutic drugs. It develops treatments for respiratory disorders, including asthma and chronic obstructive pulmonary disease.Topigen Pharmaceuticals offers TPI ASM8, a drug that is developed for the management of moderate to severe asthma; and TPI 1100, a drug that is developed for the chronic obstructive pulmonary disease.Topigen Pharmaceuticals was acquired by Pharmaxis in January 2010.Topigen Pharmaceuticals was founded in 2000 and is based in Montreal, Quebec.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$28.60M
Topigen Pharmaceuticals has raised a total of
$28.60M
in funding over 2 rounds. Their latest funding was raised on
Oct 10, 2005 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 10, 2005 | Series B | $6M | 2 | — | — | Detail |
| Dec 1, 2004 | Series Unknown | $22.60M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Topigen Pharmaceuticals is funded by 2 investors.
T2C2 Capital
and Innovatech Grand Montreal
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
T2C2 Capital
|
— | Series B |
Innovatech Grand Montreal
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
